Drug company Abbvie wins patent dispute with charity
Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Drug company Abbvie wins patent dispute with charity

Research charity The Kennedy Institute of Rheumatology Trust has lost a patent dispute to pharmaceutical company AbbVie over the rights to Humira, the world’s top-selling drug

The District Court for the Southern District of New York found last month that several claims in the patent, owned by the Kennedy Institute, were invalid.

Before the ruling, the Kennedy Trust had collected more than $100 million in royalties from AbbVie on the patent and hundreds of millions more in royalties from competitors.

The case, AbbVie and AbbVie Biotechnology v The Kennedy Institute of Rheumatology Trust, concerned the Kennedy Institute’s claims relating to US patent 7,846,442, titled “Treatment of Autoimmune and Inflammatory Disorders”. It was argued in September 2012 and the ruling was delivered on June 20 this year.

Judge Paul Crotty found claims 1 through 7, 13, 14, and 17 through 20 invalid for obviousness, and denied the Kennedy Institute’s counterclaim for a declaratory judgment that the claims in question are not invalid.

more from across site and ros bottom lb

More from across our site

The Grand Board said the applied-for mark would ‘trivialise’ one of the deadliest pandemics in history
Tim Chen Saulsbury explains why single-craft artisans inspire him and how, even at home, he’s never too far from another IP lawyer
The firm also plans to build an entertainment practice group and up its IP and antitrust offerings with a focus on foreign clients
An intimate understanding of a client’s sector is essential to winning new business, a survey of over 28,000 corporate counsel reveals
Counsel say a Federal Circuit ruling on the obviousness test for design patents may increase the time IP owners spend defending their rights
With INTA Annual Meeting over for another year, here are a few things Managing IP learned after attending IP’s biggest party
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Four sources reveal which tools they have been using – or building – to help them with a range of tasks from invention generation to claim sufficiency
Managing IP reveals Wednesday's highlights, including a discussion on how AI is helping lawyers improve their "gut instinct" trademark decisions
Managing IP reveals Tuesday’s highlights, including an illuminating discussion celebrating women in the workplace and the challenges that remain
Gift this article